L52 Erythema nodosum

Name of the Condition

• Erythema nodosum

Summary

Erythema nodosum is a skin condition characterized by the development of tender, red, raised nodules, typically on the shins. It is a form of panniculitis, an inflammation of the fat layer beneath the skin. The condition often occurs as a reaction to an underlying infection, medication, or systemic disease. Symptoms usually resolve within a few weeks but may recur or persist in some cases.

Causes

Erythema nodosum is not a disease itself but a reactive process. Common triggers include infections (such as streptococcal throat infections, tuberculosis, or fungal infections), medications (like sulfonamides or oral contraceptives), and inflammatory conditions (including sarcoidosis or inflammatory bowel disease). In some cases, no specific cause is identified.

Risk Factors

• Recent infection: Particularly streptococcal or fungal infections.
• Medication use: Certain antibiotics, hormonal treatments, or nonsteroidal anti-inflammatory drugs.
• Underlying inflammatory conditions: Such as sarcoidosis, Crohn’s disease, or ulcerative colitis.
• Gender: More common in women, especially during childbearing years.
• Age: Typically affects individuals between 20 and 40 years old.

Symptoms

• Painful, red, or purple nodules on the shins, often bilateral.
• Nodules may be warm to the touch and firm.
• Lesions may appear on the arms, thighs, or other areas in rare cases.
• Associated symptoms like fever, joint pain, or fatigue may occur.

Diagnosis

Diagnosis is based on clinical examination and patient history. A healthcare provider may perform tests to identify underlying causes, such as blood work, throat cultures, or imaging. Skin biopsy is rarely needed but can confirm the diagnosis if uncertain.

Treatment Options

• Address underlying cause: Treating the triggering infection or discontinuing the offending medication.
• Symptomatic relief: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
• Rest and elevation: Minimizing activity and elevating legs to reduce swelling.
• Corticosteroids: Used in severe or persistent cases to suppress inflammation.

Prognosis and Follow-Up

Most cases resolve within 3 to 6 weeks with appropriate management. Recurrence is possible, especially if the underlying cause is not fully addressed. Follow-up may involve monitoring for resolution and addressing any persistent symptoms or underlying conditions.

Complications

• Post-inflammatory hyperpigmentation: Darkening of the skin after lesions heal.
• Ulceration or scarring: Rare but may occur in severe or untreated cases.
• Chronicity: Prolonged inflammation if the underlying cause remains unidentified.

Lifestyle & Prevention

• Avoid triggers: Discontinue medications known to cause reactions, if possible.
• Manage infections: Promptly treat streptococcal or fungal infections.
• Supportive care: Rest, elevation, and compression may reduce discomfort.
• Monitor for recurrence: Track symptoms and report new or worsening lesions.

When to Seek Professional Help

Seek medical attention if nodules are severe, spreading, or accompanied by fever, joint pain, or difficulty breathing. Persistent symptoms beyond 6 weeks or recurrence should also prompt evaluation.

Tips for Medical Coders

Document the clinical presentation, including location, tenderness, and associated symptoms. Note any identified underlying causes (e.g., infection, medication) or diagnostic tests performed. Ensure documentation supports the use of code L52 for erythema nodosum and aligns with clinical findings.